Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Ankylosing spondylitis and axial spondyloarthritis in patients with long-term inflammatory bowel disease: Results from 20 years of follow-up in the IBSEN study.

Ossum AM, Palm Ø, Lunder AK, Cvancarova M, Banitalebi H, Negård A, Høie O, Henriksen M, Moum BA, Høivik ML; IBSEN Study Group.

J Crohns Colitis. 2017 Sep 13. doi: 10.1093/ecco-jcc/jjx126. [Epub ahead of print]

PMID:
28961700
2.

Bowel Damage in Patients With Long-term Crohn's Disease, Assessed by Magnetic Resonance Enterography and the Lémann Index.

Lunder AK, Jahnsen J, Bakstad LT, Borthne A, Hov JR, Vatn M, Negård A; IBSEN Study Group.

Clin Gastroenterol Hepatol. 2017 Jul 8. pii: S1542-3565(17)30801-7. doi: 10.1016/j.cgh.2017.06.053. [Epub ahead of print]

PMID:
28694130
3.

Risk matrix model for prediction of colectomy in a population-based study of ulcerative colitis patients (the IBSEN study).

Solberg IC, Høivik ML, Cvancarova M, Moum B; IBSEN Study Group.

Scand J Gastroenterol. 2015;50(12):1456-62. doi: 10.3109/00365521.2015.1064991. Epub 2015 Jul 3.

PMID:
26139389
4.

Risk matrix for prediction of advanced disease in a population-based study of patients with Crohn's Disease (the IBSEN Study).

Solberg IC, Cvancarova M, Vatn MH, Moum B; IBSEN Study Group.

Inflamm Bowel Dis. 2014 Jan;20(1):60-8. doi: 10.1097/01.MIB.0000436956.78220.67.

PMID:
24280875
5.

Anaemia in inflammatory bowel disease: a population-based 10-year follow-up.

Høivik ML, Reinisch W, Cvancarova M, Moum B; IBSEN study group.

Aliment Pharmacol Ther. 2014 Jan;39(1):69-76. doi: 10.1111/apt.12541. Epub 2013 Oct 31.

6.

Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).

Opheim R, Hoivik ML, Solberg IC, Moum B; IBSEN Study Group.

J Crohns Colitis. 2012 Apr;6(3):345-53. doi: 10.1016/j.crohns.2011.09.007. Epub 2011 Oct 13.

PMID:
22405172
7.

Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: ten-year results from the IBSEN study.

Høivik ML, Bernklev T, Solberg IC, Cvancarova M, Lygren I, Jahnsen J, Moum B; IBSEN Study Group.

J Crohns Colitis. 2012 May;6(4):441-53. doi: 10.1016/j.crohns.2011.10.001. Epub 2011 Nov 9.

PMID:
22398064
8.

Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study.

Hoivik ML, Moum B, Solberg IC, Cvancarova M, Hoie O, Vatn MH, Bernklev T; IBSEN Study Group.

Inflamm Bowel Dis. 2012 Aug;18(8):1540-9. doi: 10.1002/ibd.21863. Epub 2011 Sep 20.

PMID:
21936030
9.

Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis.

Hov JR, Keitel V, Laerdahl JK, Spomer L, Ellinghaus E, ElSharawy A, Melum E, Boberg KM, Manke T, Balschun T, Schramm C, Bergquist A, Weismüller T, Gotthardt D, Rust C, Henckaerts L, Onnie CM, Weersma RK, Sterneck M, Teufel A, Runz H, Stiehl A, Ponsioen CY, Wijmenga C, Vatn MH; IBSEN Study Group, Stokkers PC, Vermeire S, Mathew CG, Lie BA, Beuers U, Manns MP, Schreiber S, Schrumpf E, Häussinger D, Franke A, Karlsen TH.

PLoS One. 2010 Aug 25;5(8):e12403. doi: 10.1371/journal.pone.0012403.

10.

Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL).

Franke A, Balschun T, Sina C, Ellinghaus D, Häsler R, Mayr G, Albrecht M, Wittig M, Buchert E, Nikolaus S, Gieger C, Wichmann HE, Sventoraityte J, Kupcinskas L, Onnie CM, Gazouli M, Anagnou NP, Strachan D, McArdle WL, Mathew CG, Rutgeerts P, Vermeire S, Vatn MH; IBSEN study group, Krawczak M, Rosenstiel P, Karlsen TH, Schreiber S.

Nat Genet. 2010 Apr;42(4):292-4. doi: 10.1038/ng.553. Epub 2010 Mar 14.

PMID:
20228798
11.

Relationships between inflammatory bowel disease and perinatal factors: both maternal and paternal disease are related to preterm birth of offspring.

Bengtson MB, Solberg IC, Aamodt G, Jahnsen J, Moum B, Vatn MH; IBSEN Study Group.

Inflamm Bowel Dis. 2010 May;16(5):847-55. doi: 10.1002/ibd.21120.

PMID:
19795509
12.

Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population-based cohort followed for ten years.

Bengtson MB, Solberg C, Aamodt G, Sauar J, Jahnsen J, Moum B, Lygren I, Vatn MH; IBSEN study group.

J Crohns Colitis. 2009 Jun;3(2):92-9. doi: 10.1016/j.crohns.2008.11.002. Epub 2008 Dec 21.

PMID:
21172251
13.

Clustering in time of familial IBD separates ulcerative colitis from Crohn's disease.

Bengtson MB, Solberg C, Aamodt G, Jahnsen J, Moum B, Sauar J, Vatn MH; Ibsen Study Group.

Inflamm Bowel Dis. 2009 Dec;15(12):1867-74. doi: 10.1002/ibd.20978. Epub 2009 May 11.

PMID:
19434721
14.

Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).

Solberg IC, Lygren I, Jahnsen J, Aadland E, Høie O, Cvancarova M, Bernklev T, Henriksen M, Sauar J, Vatn MH, Moum B; IBSEN Study Group.

Scand J Gastroenterol. 2009;44(4):431-40. doi: 10.1080/00365520802600961.

PMID:
19101844
15.

Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease.

Solberg IC, Lygren I, Cvancarova M, Jahnsen J, Stray N, Sauar J, Schreiber S, Moum B, Vatn MH; IBSEN Study Group.

Inflamm Bowel Dis. 2009 Mar;15(3):406-14. doi: 10.1002/ibd.20781.

PMID:
19009607
16.

Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility.

Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, Mayr G, Domingues FS, Albrecht M, Nothnagel M, Ellinghaus D, Sina C, Onnie CM, Weersma RK, Stokkers PC, Wijmenga C, Gazouli M, Strachan D, McArdle WL, Vermeire S, Rutgeerts P, Rosenstiel P, Krawczak M, Vatn MH; IBSEN study group, Mathew CG, Schreiber S.

Nat Genet. 2008 Nov;40(11):1319-23. doi: 10.1038/ng.221. Epub 2008 Oct 5.

PMID:
18836448
17.

The association between water supply and inflammatory bowel disease based on a 1990-1993 cohort study in southeastern Norway.

Aamodt G, Bukholm G, Jahnsen J, Moum B, Vatn MH; IBSEN Study Group.

Am J Epidemiol. 2008 Nov 1;168(9):1065-72. doi: 10.1093/aje/kwn218. Epub 2008 Sep 18.

PMID:
18801890
18.

C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.

Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B; IBSEN Study Group.

Gut. 2008 Nov;57(11):1518-23. doi: 10.1136/gut.2007.146357. Epub 2008 Jun 19.

PMID:
18566104
19.

Geographic distribution and ecological studies of inflammatory bowel disease in southeastern Norway in 1990-1993.

Aamodt G, Jahnsen J, Bengtson MB, Moum B, Vatn MH; IBSEN Study Group.

Inflamm Bowel Dis. 2008 Jul;14(7):984-91. doi: 10.1002/ibd.20417.

PMID:
18338775
20.

The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases.

Eike MC, Nordang GB, Karlsen TH, Boberg KM, Vatn MH; IBSEN study group, Dahl-Jørgensen K, Rønningen KS, Joner G, Flatø B, Bergquist A, Thorsby E, Førre O, Kvien TK, Undlien DE, Lie BA.

Ann Rheum Dis. 2008 Sep;67(9):1287-91. Epub 2007 Dec 7.

PMID:
18065500

Supplemental Content

Loading ...
Support Center